Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ABUS

Arbutus Biopharma Corporation

Healthcare · USD

Set alert

Price alert · ABUS

All alert types
4.21 USD -0.07 -1.64%
As of Oct 30, 2026 Extended hours 4.21 0.00%
Bid
4.21 × 2
Ask
4.22 × 2
4.14 Day range 4.30
3.67 52-week range 5.22
YTD
-12.47%
1 year
-13.02%
Open
4.28
Prev close
4.28
Mkt cap
645.29M
Vol
2.53M
Avg vol
4.88M
EPS
0.79
P/E
5.33
Div yield
0.00%
More statistics
Low
4.14
High
4.30
Forward P/E
-30.67
Beta
0.62
Short ratio
5.03
Inst. own
72.71%
Dividend
0.00
Ex-div date
Earnings
Nov 16, 2026
50-d avg
4.79
200-d avg
4.52
1y target
5.46

MAX chart

Chart tools
Interval
1m5m15m30m
ABUS all-time price chart0.828.4816.123.831.5Aug 07Jun 11Apr 15Mar 19Jan 23Oct 26

Financial health

Altman Z-Score

30.21 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 2

Valuation

P/E -28.3×
FY 2016: -0.3×FY 2017: -3.3×FY 2018: -3.7×FY 2019: -1.0×FY 2020: -4.1×FY 2021: -5.3×FY 2022: -5.1×FY 2023: -5.7×FY 2024: -8.6×FY 2025: -28.3×
FY 2016 5y median -5.7× FY 2025
P/S 65.4×
FY 2016: 86.7×FY 2017: 25.8×FY 2018: 35.9×FY 2019: 26.4×FY 2020: 38.9×FY 2021: 37.6×FY 2022: 9.0×FY 2023: 22.9×FY 2024: 98.4×FY 2025: 65.4×
FY 2016 5y median 37.6× FY 2025
P/B 12.0×
FY 2016: 0.6×FY 2017: 1.5×FY 2018: 1.1×FY 2019: 2.2×FY 2020: 2.6×FY 2021: 2.4×FY 2022: 2.6×FY 2023: 3.9×FY 2024: 6.2×FY 2025: 12.0×
FY 2016 5y median 3.9× FY 2025
P/FCF -23.3×
FY 2016: -2.1×FY 2017: -4.9×FY 2018: -3.1×FY 2019: -2.2×FY 2020: -5.2×FY 2021: -6.0×FY 2022: -9.8×FY 2023: -4.8×FY 2024: -9.3×FY 2025: -23.3×
FY 2016 5y median -9.3× FY 2025
EV/EBITDA -27.5×
FY 2016: -0.2×FY 2017: -2.2×FY 2018: -3.0×FY 2019: -0.8×FY 2020: -4.1×FY 2021: -4.5×FY 2022: -5.4×FY 2023: -5.6×FY 2024: -8.4×FY 2025: -27.5×
FY 2016 5y median -5.6× FY 2025
EV/Sales 64.5×
FY 2016: 79.1×FY 2017: 21.9×FY 2018: 29.6×FY 2019: 21.7×FY 2020: 34.6×FY 2021: 29.4×FY 2022: 8.5×FY 2023: 21.9×FY 2024: 93.5×FY 2025: 64.5×
FY 2016 5y median 29.4× FY 2025
FCF Yield -4.3%
FY 2016: -47.6%FY 2017: -20.2%FY 2018: -32.6%FY 2019: -45.1%FY 2020: -19.2%FY 2021: -16.5%FY 2022: -10.2%FY 2023: -21.0%FY 2024: -10.7%FY 2025: -4.3%
FY 2016 5y median -10.7% FY 2025

Profitability

Gross Margin 97.4%
FY 2016: -3986.7%FY 2017: -486.0%FY 2018: -881.4%FY 2019: -858.3%FY 2020: -586.7%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 97.4%
FY 2016 5y median 100.0% FY 2025
Operating Margin -192.1%
FY 2016: -32773.3%FY 2017: -1036.4%FY 2018: -1522.0%FY 2019: -2394.0%FY 2020: -836.1%FY 2021: -669.1%FY 2022: -167.8%FY 2023: -430.5%FY 2024: -1236.7%FY 2025: -192.1%
FY 2016 5y median -430.5% FY 2025
Net Margin -237.9%
FY 2016: -25606.7%FY 2017: -788.8%FY 2018: -967.8%FY 2019: -2557.4%FY 2020: -922.0%FY 2021: -693.9%FY 2022: -178.0%FY 2023: -401.6%FY 2024: -1133.0%FY 2025: -237.9%
FY 2016 5y median -401.6% FY 2025
ROE -43.7%
FY 2016: -189.2%FY 2017: -46.2%FY 2018: -28.5%FY 2019: -211.3%FY 2020: -62.5%FY 2021: -45.0%FY 2022: -50.8%FY 2023: -68.7%FY 2024: -71.8%FY 2025: -43.7%
FY 2016 5y median -50.8% FY 2025
ROIC -30.3%
FY 2016: -145.5%FY 2017: -38.2%FY 2018: -38.5%FY 2019: -135.6%FY 2020: -45.2%FY 2021: -38.0%FY 2022: -40.2%FY 2023: -63.8%FY 2024: -65.5%FY 2025: -30.3%
FY 2016 5y median -40.2% FY 2025
ROA -35.4%
FY 2016: -139.2%FY 2017: -35.6%FY 2018: -25.1%FY 2019: -145.7%FY 2020: -46.5%FY 2021: -37.3%FY 2022: -35.5%FY 2023: -50.4%FY 2024: -53.1%FY 2025: -35.4%
FY 2016 5y median -37.3% FY 2025

Growth (YoY)

Revenue 128.2%
FY 2016: -94.0%FY 2017: 613.3%FY 2018: -44.9%FY 2019: 1.9%FY 2020: 15.0%FY 2021: 58.9%FY 2022: 255.1%FY 2023: -53.5%FY 2024: -66.0%FY 2025: 128.2%
FY 2016 FY 2025
Operating Income 64.6%
FY 2016: -380.4%FY 2017: 77.4%FY 2018: 19.0%FY 2019: -60.2%FY 2020: 59.8%FY 2021: -27.2%FY 2022: 11.0%FY 2023: -19.3%FY 2024: 2.3%FY 2025: 64.6%
FY 2016 FY 2025
EPS (diluted) 55.3%
FY 2016: -440.3%FY 2017: 78.7%FY 2018: 33.1%FY 2019: -161.2%FY 2020: 68.0%FY 2021: 15.1%FY 2022: 37.0%FY 2023: 4.3%FY 2024: 13.6%FY 2025: 55.3%
FY 2016 FY 2025
Free Cash Flow 39.1%
FY 2016: -8.4%FY 2017: 9.7%FY 2018: -23.6%FY 2019: -3.7%FY 2020: 27.8%FY 2021: -32.3%FY 2022: 47.5%FY 2023: -142.4%FY 2024: 25.2%FY 2025: 39.1%
FY 2016 FY 2025

Financial Health

Current Ratio 15.7×
FY 2016: 12.5×FY 2017: 10.9×FY 2018: 11.5×FY 2019: 12.0×FY 2020: 13.4×FY 2021: 14.3×FY 2022: 4.6×FY 2023: 5.9×FY 2024: 8.2×FY 2025: 15.7×
FY 2016 5y median 8.2× FY 2025
Quick Ratio 15.7×
FY 2016: 12.5×FY 2017: 10.9×FY 2018: 11.5×FY 2019: 12.0×FY 2020: 13.4×FY 2021: 14.3×FY 2022: 4.6×FY 2023: 5.9×FY 2024: 8.2×FY 2025: 15.7×
FY 2016 5y median 8.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.0×FY 2017: 0.4×FY 2018: 0.6×FY 2019: 0.2×FY 2020: 0.5×FY 2021: 1.3×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -279×
FY 2016: 0.0×FY 2017: -425×FY 2018: -449×FY 2019: -68.3×FY 2020: -14.4×FY 2021: -25.7×FY 2022: -37.9×FY 2023: -170×FY 2024: -557×FY 2025: -279×
FY 2016 5y median -170× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 4.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 2.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -17.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -15.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31